No Data
No Data
Cipla Wants to Partner With Eli Lilly (NYSE:LLY) in India
Express News | NYSE Order Imbalance 56943.0 Shares on Buy Side
Market Chatter: Cipla Open to Partner With Eli Lilly to Market Obesity Drugs in India
Eli Lilly (LLY) could partner with Indian drugmaker Cipla to market its weight-loss drugs in India, Reuters reported Friday, citing Cipla's Global CEO Umang Vohra. Cipla has an existing partnership to
Lilly Could Partner With Cipla to Market GLP-1 Drugs in India - Report
Pharma Stock Roundup: PFE DMD Study Patient Death, FDA Panel Meet for LLY's Donanemab
One in Eight U.S. Adults Admits to GLP-1 Usage as Public Awareness Surges
No Data